Introduction
MB ("myocardial type") and creatine kinase BB ("brain type"). The differentiation of these isoenzymes has Creatine kinase (CK; ATP: creatine phosphotransf erase, gained considerable interest, especially the measurement EC 2.7.3-2) in the human organism occurs in the form of dime« of the subunits M and B, respectively. There-'> J^^S^^^^^f ore, 3 isoenzymes can be distinguished: creatine kinase gemeinschaft (Schwerpunktprogramm "Enzymdiagnostik"
MM ("skeletal muscle type"), the hybrid creatine kinase Pr 66/6).
of creatine kinase MB catalytic concentration in serum as a parameter of myocardial damage (1) .
Several methods for the differentiation of creatine kinase isoenzymes have been published:
Electrophoretic separation in polyacrylamide gel (2) , in agar gel (3) , in agarose gel (4) und in cellulose acetate (5) , with subsequent activity measurement via NADPH fluorescence or via reduction of tetrazolium salts to formazanes.
Chromatographie separation on columns with ion exchange agarose (6) and with ion exchange cellulose (7); on glass beads covered with ion exchange groups (8) or on anion exchange polystyrene (8 a) with batch elution.
High pressure liquid chromatography separation on anion exchange columns (9) .
Differential activity measurement in the presence of different substrates (10) and of different sulfhydryl reactivators(ll).
Recently the use of precipitating antibodies has been described (12, 13, 14, 15, 16) .
In the laboratories of our group we have elaborated routine methods for the immunological differentiation of creatine kinase isoenzymes. In the following we present two methods for the measurement of creatine kinase isoenzyme catalytic concentrations in serum:
1. A method using inhibiting antibodies, which measures the activity of creatine kinase B subunits present in the sample ("Inhibition Test")' For this test inhibiting antibodies (Inh-CK-M-antibodies) are employed, which selectively and quantitatively block the activity of creatine kinase M subunits. This test is used for the measurement of serum creatine kinase MB catalytic concentrations.
2. A method using precipitating antibodies, which allows quantitative differentiation of creatine kinase isoenzymes MM, MB, and BB, respectively ("Precipitation Test"). In this test the precipitating antibodies anti-Creatinkinase-MM and anti-Creatinkinase-BB are employed. This test, in addition to its use in the differentiation of all creatine kinase isoenzymes, is proposed as a control in cases of suspected creatine kinase BB activity in combination with the Inhibition Test.
Procedure, specificity, correlation and application of these methods are discussed.
Experimental Procedures and Results

Inhibition Test
Reagents Preparation of creatine kinase MM human by a modified procedure according to Keutel et al. (17) . Specific activity of the enzyme used for immunization = 320 U/mg protein. 
Model experiments
To demonstrate the degree of inhibition of creatine kinase isoenzymes by Inh-CIGM-antibodies, model experiments are performed on inactivated human sera, to which measured amounts of purified human creatine kinase isoenzymes are added. For the preparation and specific activities of creatine kinase MM and BB used, see chapter "Precipitation test, reagents". Creatine kinase MB is prepared by reversible dissociation of an equal mixture of creatine kinase MM plus BB in 3.6 mol/1 guanidinium chloride followed by Chromatographie separation on DEAE agarose. Specific activity of the creatine kinase MB preparation used = 330 U/mg protein. The experiments are 5-fold determinations with an intraserial CV of 1.99%. Table 1 contains the results of these measurements. Within the limits of error the following percentage of activity inhibition is obtained: creatine kinase MM = 100%, creatine kinase MB = 50%, creatine kinase BB = 0%. These figures are valid in the total range of catalytic concentrations for which this test has been conceived.
These figures, however, are mean values. Considering the ± 2 SD range, the inhibition of creatine kinase MB activity by Inh^CK-M-antibodies is between 45 and 56% (not taking into account the larger variation with the value of 18 U/l CK-MB). This range possibly represents not only methodological errors, but also a difference in the specific activity against creatine phosphate of creatine kinase M and B subunits, respectively, or a possible allosteric effect on the ereatine kinase B sub* unit within the MB dimer effected by the binding of the antibody to the M subunit. This problem is being investigated.
Tab. 1. Inhibition of creatine kinase isoenzyme catalytic concentrations by inhibiting creatine kinase M antibodies. Inactivated human sera with addition of purified human creatine kinase isoenzymes. Mean ± 1 SD from 5 fold determinations. 
Further characterization of inhibiting antibodies
The inhibitory action of Inh-CK-M-antibodies can be shown to be a primary interaction with the enzyme molecule (no precipitation) by use of monovalent antibody fragments. Fab and Fc fragments are produced from Inh-CK-M-antibody by a modified procedure according to Porter (22) . The inhibition of creatine kinase MM activity by Inh-CK-M-antibody, Fab and Fc, respectively, was measured at different concentrations of these proteins. The results are presented in figure 1. Fab fragments inhibit creatine kinase MM activity to 100%, the inhibition characteristics being the same as with complete antibodies. Fc fragments yield no inhibition of creatine kinase MM activity, as is to be expected.
The influence of the animal species used to raise antibodies on the specificity of Inh-CK^M-antibodies is shown in figure 2 . The inhibition of creatine kinase MB activity by antibodies from different animal species is plotted against the antibody concentration. Only goat antibodies yield 50% inhibition of creatine kinase MB activity, this value being constant over a broad concentration range. Rabbit and sheep antibodies at high concentrations inhibit creatine kinase MB activity by more than 50%, which means that besides creatine kinase M subunit activity, B subunit activity is also partially inhibited.
The influence of the antigen used for immunization on the specificity of the resulting antibodies is shown in figure 3 . The inhibition of creatine kinase MB activityis plotted against the antibody concentration. Besides human creatine kinase MM, creatine kinase MM from rhesus skeletal muscle also gives rise to antibodies in the goat, which inhibit human creatine kinase MB by 50%. Antibodies raised against creatine kinase MM from 
Precision
Measurements of creatine kinase MB catalytic concentration in control samples (pooled sera of patients with myocardial infarction and myocardial extracts) give the following results:
Intraserial precision: CV= 13% at 13 U/l, CV= 5% at 32 U/l, CV= 2% at 72 U/l (18) .
Precision from day to day: χ = 36 U/l, SD = 3.0 U/l, CV = 8.3%, n = 27 (18) , χ = 46 U/l, SD = 2.5 U/l, CV = 5.5%, n = 14 (19) .
Long term precision in serum: χ = 33 U/l, SD = 5.1 U/l, CV = 6.9%, n = 94 (23) .
Long term precision in myocardial extracts: χ = 174 U/l, SD = 11.8 U/l, CV = 6,7%, n = 41 (23) .
Performing the test with double determinations plus deduction of the reagent blank, creatine kinase MB catalytic concentrations of 3 U/l can be distinguished from zero level (95% niveau) (18) . Performing the test with single determinations without measurement of the reagent blank, creatine kinase MB catalytic concentrations of about 10 U/l can be distinguished from background level. the activity of all creatine kinase B subunits present in the sample is measured after inhibition of the creatine kinase M subunit activity, differentiation between creatine kinase MB and BB is not possible.
Comparison of Methods
Parallel measurements with the Inhibition Test and the Precipitation Test of creatine kinase MB catalytic concentrations are performed in sera of patients suffering from myocardial infarction and other diseases. The results are presented as a correlation plot in figure 6 . 
Discussion
The two methods described here for measurement of creatine kinase isoenzyme catalytic concentrations utilize different aspects of the antigen-antibody-reaction:
The Inhibition Test is based on the primary immiiriological reaction, the binding of antibodies to the enzyme protein with concurrent inhibition of enzymatic activity. This reaction mechanism has been proved by use of monovalent antibody fragments, which show equal enzyme.inhibition. Utilization of the primary irnmunological reaction leads to a short reaction time. Because
The Precipitation Test represents in immunological terms a secondary reaction, the formation of a cross linked insoluble immuno precipitate. This leads to a long reaction time, but the differentiation of all creatine kinase isoenzymes is possible. Measurement of creatine kinase MM and BB catalytic concentrations yields results with standard deviations in the usual range; measurement of creatine kinase MB catalytic concentrations, however, yields results with very large standard deviation, caused by error multiplication in the difference calculation.
The principles of both tests outlined above lead to their application in creatine kinase isoenzyme differentiation: The Inhibition Test is used for fast and quantitative measurement of creatine kinase MB catalytic concentrations in serum. Prerequisite for this use is the fact that creatine kinase BB activities never or only rarely occur in serum. The debate about the frequency of occurrence of creatine kinase BB activities in serum (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) is approaching the point where it is accepted that creatine kinase BB activities in serum are found only in exceptional cases. In the authors' investigations, confirmed creatine kinase BB activities have been observed in 2 out of about 15 000 routine measurements. The specificity of the Inhibition Test will not be impaired significantly, therefore, by creatine kinase BB. The Precipitation Test can be used in doubtful cases as a safety check on the Inhibition Test. Because the precipitating antiserum anti-CK-MM will precipitate creatine kinase MM plus MB, it is possible to check with a single precipitation, whether a suspected serum sample cont ains creatine kinase BB activity or not.
The measured correlation of both methods is sufficient for this suggested use of the Precipitation Test as safety check for creatine kinase BB. In the Precipitation Test all sera showing total creatine kinase catalytic concentrations over 90 U/l have to be diluted. In view of the present knowledge about the variation of creatine kinase catalytic concentrations after dilution of sera, a better correlation could not therefore be expected. ' The results of measurements of creatine kinase isoenzyme catalytic concentrations in sera of patients with different diseases using the tests described are being published separately by several groups of authors (13-16, 18, 19,23,24,34,35) .
